Biogen Idec Inc. (BIIB) News Nov 18, 2014, 6:06 p.
Post# of 250665
Posted On: 11/18/2014 9:48:09 PM
Biogen Idec Inc. (BIIB) News Nov 18, 2014, 6:06 p.m.
MarketWatch News on BIIB
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn
Loading more headlines...
Advertisement
Other News on BIIB
Kite Pharma Gains on Positive Opinion for KTE-C19 - Analyst Blog 5:30 p.m. Today - Zacks.com
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog 1:20 p.m. Today - Zacks.com
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% - Tale of the Tape 9:25 a.m. Today - Zacks.com
Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14) 6:40 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us 8:09 p.m. Nov. 17, 2014 - TheStreet.com
Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog 6:40 p.m. Nov. 17, 2014 - Zacks.com
Is Mallinckrodt (MNK) Poised to Beat Q4 Earnings Estimates? - Analyst Blog 5:30 p.m. Nov. 17, 2014 - Zacks.com
Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog 5:20 p.m. Nov. 17, 2014 - Zacks.com
Puma Biotechnology Falls on Disappointing Neratinib Data - Analyst Blog 2:04 p.m. Nov. 17, 2014 - Zacks.com
Gilead Has Been Rocked After Earnings, But I'm Looking To Buy! 12:35 p.m. Nov. 17, 2014 - Seeking Alpha
Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog 10:42 a.m. Nov. 17, 2014 - Zacks.com
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
MS Drug Gets FDA Approval 12:36 p.m. Nov. 15, 2014 - The Wall Street Journal Interactive Edition
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog 6:13 p.m. Nov. 14, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Biotech Stocks Hit: Stock Market To See New Leaders? 5:22 p.m. Nov. 14, 2014 - Investors Business Daily
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog 4:30 p.m. Nov. 14, 2014 - Zacks.com
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog 3:39 p.m. Nov. 14, 2014 - Zacks.com
Loading more headlines...
Press Releases on BIIB
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Today - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Loading more headlines...
MarketWatch News on BIIB
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn
Loading more headlines...
Advertisement
Other News on BIIB
Kite Pharma Gains on Positive Opinion for KTE-C19 - Analyst Blog 5:30 p.m. Today - Zacks.com
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog 1:20 p.m. Today - Zacks.com
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% - Tale of the Tape 9:25 a.m. Today - Zacks.com
Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14) 6:40 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: When Bad News Is Really Good News for Us 8:09 p.m. Nov. 17, 2014 - TheStreet.com
Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog 6:40 p.m. Nov. 17, 2014 - Zacks.com
Is Mallinckrodt (MNK) Poised to Beat Q4 Earnings Estimates? - Analyst Blog 5:30 p.m. Nov. 17, 2014 - Zacks.com
Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog 5:20 p.m. Nov. 17, 2014 - Zacks.com
Puma Biotechnology Falls on Disappointing Neratinib Data - Analyst Blog 2:04 p.m. Nov. 17, 2014 - Zacks.com
Gilead Has Been Rocked After Earnings, But I'm Looking To Buy! 12:35 p.m. Nov. 17, 2014 - Seeking Alpha
Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog 10:42 a.m. Nov. 17, 2014 - Zacks.com
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
MS Drug Gets FDA Approval 12:36 p.m. Nov. 15, 2014 - The Wall Street Journal Interactive Edition
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog 6:13 p.m. Nov. 14, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Biotech Stocks Hit: Stock Market To See New Leaders? 5:22 p.m. Nov. 14, 2014 - Investors Business Daily
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog 4:30 p.m. Nov. 14, 2014 - Zacks.com
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog 3:39 p.m. Nov. 14, 2014 - Zacks.com
Loading more headlines...
Press Releases on BIIB
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Today - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Loading more headlines...
(0)
(0)